Rezolute Inc is trading 5.2% down at $3.87 amid continued volatility following last week’s sharp rally and recent pullbacks.
- The move appears to be part of normal post-rally consolidation for the speculative biotech name, as there are no fresh company-specific headlines, SEC filings, or analyst rating changes reported this morning.
- Broader U.S. indices are also trading lower, which can amplify downside pressure in higher-beta stocks.